SPONSOR
Intra-Cellular Therapies, Inc.
Total Trials
3
Recruiting
3
Phases
Phase 2
Intra-Cellular Therapies, Inc. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Psychotic Disorders, Alzheimer Disease, Generalized Anxiety Disorder.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Intra-Cellular Therapies, Inc.
How many clinical trials has Intra-Cellular Therapies, Inc. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Intra-Cellular Therapies, Inc., of which 3 are actively recruiting participants. These trials cover conditions including Psychotic Disorders, Alzheimer Disease, Generalized Anxiety Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Intra-Cellular Therapies, Inc. research focus on?
Intra-Cellular Therapies, Inc. clinical trials span Psychotic Disorders, Alzheimer Disease, Generalized Anxiety Disorder. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Intra-Cellular Therapies, Inc. clinical trial?
To participate in a Intra-Cellular Therapies, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Intra-Cellular Therapies, Inc. trials with current recruitment status updated daily.
Clinical Trials by Intra-Cellular Therapies, Inc.
NCT06540833 Phase 2
Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Psychotic Disorders
NCT06701903 Phase 2
Recruiting
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Generalized Anxiety Disorder
NCT06480383 Phase 2
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Generalized Anxiety Disorder
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology